- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Eli Lilly escalates oral SERD battle with FDA approval for Inluriyo, Verzenio combo | ||
| Fr | Europe's CHMP endorses slew of new medicines, including new offerings from Novo and AstraZeneca | ||
| Fr | Panthers and zebras and meerkats, oh my: A peek behind the curtain at Fierce Pharma Week 2026 | ||
| Fr | Fierce Pharma Asia-China deals safe from COINS?; Key WCLC data; Legend's new CEO | ||
| Do | FDA approves Ultragenyx's gene therapy Fayuvi for rare neurodegenerative disorder | ||
| Do | Eli Lilly dishes out fresh produce to cultivate Alzheimer's awareness | ||
| Do | Bayer's Kerendia secures FDA nod as first drug in 30 years for Type 1 diabetes-associated kidney disease | ||
| Do | Roche's Lunsumio delivers positive confirmatory trial readout in follicular lymphoma | ||
| Do | Bavarian Nordic secures Sanofi, AstraZeneca vet to fill shoes of longtime CEO Paul Chaplin | ||
| Do | Sun Pharma shines a light on alopecia areata in 'Regrowth Restyled' campaign | ||
| Do | FDA drops warning letter on Bausch & Lomb, citing contamination concerns | ||
| Do | 'People like the sincerity of it': comedian Damon Wayans on humor, relatability and DME awareness in Genentech campaign | ||
| Do | Ex-PHM CEO Andrea Palmer takes top job at Assembled Intelligence | ||
| Mi | Vera's strong phase 3 IgAN data for Trutakna intensify kidney disease rivalry | ||
| Mi | Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts | ||
| Mi | Trialynx Wins DPHARM Idol Disrupt 2026 | ||
| Mi | BMS, Ono take Amgen to task as FDA's Opdivo biosimilar decision looms | ||
| Mi | Reckitt allots $600 million in upgrade of its U.S. operations | ||
| Mi | Legend Biotech names Novartis veteran Ingrid Zhang as new CEO | ||
| Mi | Ori locks down $120M pact to deploy automated production platform for unnamed, commercial cell therapy | ||
| Di | BioMarin drops Voxzogo development for Noonan syndrome as treatment landscape shifts | ||
| Di | Sanofi strikes Cheplapharm deal to divest 20 older medicines as CEO pushes for innovation | ||
| Di | AbbVie chips in for neurology advocacy through PGA Tour birdie campaign | ||
| Di | Olympic skier Lindsey Vonn joins up with Vertex for pain campaign | ||
| Di | FDA approves first radioligand equivalent, Curium's copycat of Novartis' Lutathera |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.